SCHEMBL25780148

SCHEMBL25780148

Cn1c(CCO)cc2cc(Cl)cnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ PABPC1 P11940 1/20 0.41
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ ABL1 P00519 1/20 0.31
▸ PDGFRB P09619 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ PDGFRA P16234 1/20 0.31
▸ MAPK14 Q16539 1/20 0.31
▸ HRH4 Q9H3N8 3/20 0.30
▸ HRH3 Q9Y5N1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25775975 0.87 HPGD (0.44) HPGDHTTHSD17B10KMT2AMEN1
SCHEMBL25780218 0.86 HPGD (0.36) HPGDHTTHSD17B10KMT2AMEN1
SCHEMBL25780241 0.77 MYC (0.37) HPGDHTTHSD17B10KMT2AMEN1
SCHEMBL25780149 0.77 HPGD (0.37) HPGDHTTHSD17B10KMT2AMEN1
SCHEMBL25775979 0.74 MAOA (0.42) HPGDHTTKMT2AKDM4EALDH1A1
SCHEMBL25776140 0.74 CYP1A2 (0.40) HPGDHTTKMT2AMEN1LMNA
SCHEMBL31369943 0.74 SLC1A3 (0.42) HPGDHTTHSD17B10KMT2AMEN1
SCHEMBL30731237 0.71 HSD17B10 (0.47) HPGDHTTHSD17B10KMT2AMEN1
SCHEMBL25783244 0.69 IRAK4 (0.41) —
SCHEMBL25775977 0.68 HSD17B10 (0.47) HPGDHTTHSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023115203-A1 OXER1 ANTAGONISTS AND USES THEREOF FAIRHAVEN PHARMACEUTICALS INC. (CA) 2023-06-29 — — WO disclosed
Send feedback